메뉴 건너뛰기




Volumn 13, Issue 7, 2004, Pages 1250-1252

Irreversible ototoxicity associated with difluoromethylornithine

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE;

EID: 3142681067     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (28)
  • 1
    • 0345535621 scopus 로고    scopus 로고
    • Development of difluoromethylornithine (DFMO) as a chemoprevention agent
    • Meyskens FL Jr, Gerner EW. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999;5:945-51.
    • (1999) Clin Cancer Res , vol.5 , pp. 945-951
    • Meyskens Jr., F.L.1    Gerner, E.W.2
  • 2
    • 0021343859 scopus 로고
    • Phase I trial and pharmacokinetic studies of α- difluoromethylornithine - An inhibitor of polyamine biosynthesis
    • Abeloff MD, Slavik M, Luk GD, et al. Phase I trial and pharmacokinetic studies of α-difluoromethylornithine-an inhibitor of polyamine biosynthesis. J Clin Oncol 1984;2:124-30.
    • (1984) J Clin Oncol , vol.2 , pp. 124-130
    • Abeloff, M.D.1    Slavik, M.2    Luk, G.D.3
  • 3
    • 0023690550 scopus 로고
    • A phase I trial of recombinant interferon-α and α-difluoromethylornithine in metastatic melanoma
    • Croghan MK, Booth A, Meyskens FL Jr. A phase I trial of recombinant interferon-α and α-difluoromethylornithine in metastatic melanoma. J Biol Response Modif 1988;7:409-15.
    • (1988) J Biol Response Modif , vol.7 , pp. 409-415
    • Croghan, M.K.1    Booth, A.2    Meyskens Jr., F.L.3
  • 4
    • 0022999939 scopus 로고
    • A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma
    • Meyskens FL, Kingsley EM, Glattke T, Loescher L, Booth A. A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Invest New Drugs 1986;4:257-62.
    • (1986) Invest New Drugs , vol.4 , pp. 257-262
    • Meyskens, F.L.1    Kingsley, E.M.2    Glattke, T.3    Loescher, L.4    Booth, A.5
  • 5
    • 0022499206 scopus 로고
    • Phase II trials of α-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer
    • Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoerdsma A. Phase II trials of α-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat Rep 1986;70:843-5.
    • (1986) Cancer Treat Rep , vol.70 , pp. 843-845
    • Abeloff, M.D.1    Rosen, S.T.2    Luk, G.D.3    Baylin, S.B.4    Zeltzman, M.5    Sjoerdsma, A.6
  • 6
    • 0025311468 scopus 로고
    • Evaluation of continuous-infusion α-difluoromethylornithine therapy for colorectal carcinoma
    • Ajani JA, Ota DM, Grossie VB Jr, et al. Evaluation of continuous-infusion α-difluoromethylornithine therapy for colorectal carcinoma. Cancer Chemother Pharmacol 1990;26:223-6.
    • (1990) Cancer Chemother Pharmacol , vol.26 , pp. 223-226
    • Ajani, J.A.1    Ota, D.M.2    Grossie Jr., V.B.3
  • 8
    • 0031454230 scopus 로고    scopus 로고
    • α-Difluoromethylornithine ototoxicity. Chemoprevention clinical trial results
    • Pasic TR, Heisey D, Love RR. α-Difluoromethylornithine ototoxicity. Chemoprevention clinical trial results. Arch Otolaryngol Head Neck Surg 1997;123:1281-6.
    • (1997) Arch Otolaryngol Head Neck Surg , vol.123 , pp. 1281-1286
    • Pasic, T.R.1    Heisey, D.2    Love, R.R.3
  • 9
    • 0027601440 scopus 로고
    • Evaluation of α-difluoromethylornithine as a potential chemopreventive agent: Tolerance to daily oral administration in humans
    • Creaven PJ, Pendyala L, Petrelli NJ. Evaluation of α- difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans. Cancer Epidemiol, Biomarkers & Prev 1993;2:243-7.
    • (1993) Cancer Epidemiol, Biomarkers & Prev , vol.2 , pp. 243-247
    • Creaven, P.J.1    Pendyala, L.2    Petrelli, N.J.3
  • 11
    • 0027983571 scopus 로고
    • Dose de-escalation chemoprevention trial of α- difluoromethylornithine in patients with colon polyps
    • Meyskens FL Jr, Emerson SS, Pelot D, et al. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994;86:1122-30.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1122-1130
    • Meyskens Jr., F.L.1    Emerson, S.S.2    Pelot, D.3
  • 12
    • 0027266833 scopus 로고
    • Randomized phase I chemoprevention dose-seeking study of α-difluoromethylornithine
    • Love RR, Carbone PP, Verma AK, et al. Randomized phase I chemoprevention dose-seeking study of α-difluoromethylornithine. J Natl Cancer Inst 1993;85:732-37.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 732-737
    • Love, R.R.1    Carbone, P.P.2    Verma, A.K.3
  • 14
    • 0031889260 scopus 로고    scopus 로고
    • Phase I dose deescalation trial of α-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia
    • Mitchell MF, Tortolero-Luna G, Lee JJ, et al. Phase I dose deescalation trial of α-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clin Cancer Res 1998;4:303-10.
    • (1998) Clin Cancer Res , vol.4 , pp. 303-310
    • Mitchell, M.F.1    Tortolero-Luna, G.2    Lee, J.J.3
  • 16
    • 0031733846 scopus 로고    scopus 로고
    • A randomized, placebocontrolled trial of low-dose α- difluoromethylornithine in individuals at risk for colorectal cancer
    • Love RR, Jacoby R, Newton MA, et al. A randomized, placebocontrolled trial of low-dose α-difluoromethylornithine in individuals at risk for colorectal cancer. Cancer Epidemiol, Biomarkers & Prev 1998;7:989-92.
    • (1998) Cancer Epidemiol, Biomarkers & Prev , vol.7 , pp. 989-992
    • Love, R.R.1    Jacoby, R.2    Newton, M.A.3
  • 17
    • 0042098091 scopus 로고    scopus 로고
    • Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention
    • Meyskens FL Jr, Gerner EW, Emerson S, et al. Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 1998;90:1212-8.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1212-1218
    • Meyskens Jr., F.L.1    Gerner, E.W.2    Emerson, S.3
  • 19
    • 0035869019 scopus 로고    scopus 로고
    • Recommendations for cancer prevention trials using potentially ototoxic test agents
    • Shotland LI, Ondrey FG, Mayo KA, Viner JL. Recommendations for cancer prevention trials using potentially ototoxic test agents. J Clin Oncol 2001;19:1658-63.
    • (2001) J Clin Oncol , vol.19 , pp. 1658-1663
    • Shotland, L.I.1    Ondrey, F.G.2    Mayo, K.A.3    Viner, J.L.4
  • 20
    • 0025363392 scopus 로고
    • Cochlear damage and increased threshold in α- difluoromethylornithine (DFMO) treated guinea pigs
    • Salzer SJ, Mattox DE, Brownell WE. Cochlear damage and increased threshold in α-difluoromethylornithine (DFMO) treated guinea pigs. Hear Res 1990;46:101-12.
    • (1990) Hear Res , vol.46 , pp. 101-112
    • Salzer, S.J.1    Mattox, D.E.2    Brownell, W.E.3
  • 23
    • 0028097041 scopus 로고
    • Spermine and spermidine as gating molecules for inward rectifier K+ channels
    • Ficker E, Taglialatela M, Wible BA, Henley CM, Brown AM. Spermine and spermidine as gating molecules for inward rectifier K+ channels. Science 1994;266:1068-72.
    • (1994) Science , vol.266 , pp. 1068-1072
    • Ficker, E.1    Taglialatela, M.2    Wible, B.A.3    Henley, C.M.4    Brown, A.M.5
  • 24
    • 0033288042 scopus 로고    scopus 로고
    • Auditory deprivation of the central auditory system resulting from selective inner hair cell loss: Animal model of auditory neuropathy
    • Salvi RJ, Wang J, Ding D, Stecker N, Arnold S. Auditory deprivation of the central auditory system resulting from selective inner hair cell loss: animal model of auditory neuropathy. Scand Audiol Suppl 1999;51:1-12.
    • (1999) Scand Audiol Suppl , vol.51 , pp. 1-12
    • Salvi, R.J.1    Wang, J.2    Ding, D.3    Stecker, N.4    Arnold, S.5
  • 25
    • 0033949479 scopus 로고    scopus 로고
    • Characterization of the ototoxicity of difluoromethylornithine and its enantiomers
    • McWilliams ML, Chen GD, Fechter LD. Characterization of the ototoxicity of difluoromethylornithine and its enantiomers. Toxicol Sci 2000;56:124-32.
    • (2000) Toxicol Sci , vol.56 , pp. 124-132
    • McWilliams, M.L.1    Chen, G.D.2    Fechter, L.D.3
  • 26
    • 0027383434 scopus 로고
    • Ototoxicity of chemotherapeutic agents
    • Schweitzer VG. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 1993;26:759-89.
    • (1993) Otolaryngol Clin North Am , vol.26 , pp. 759-789
    • Schweitzer, V.G.1
  • 27
    • 0015013715 scopus 로고
    • Primary structural changes in the organ of Corti after acoustic overstimulation
    • Spoendlin H. Primary structural changes in the organ of Corti after acoustic overstimulation. Acta Otolaryngol 1971;71:166-76.
    • (1971) Acta Otolaryngol , vol.71 , pp. 166-176
    • Spoendlin, H.1
  • 28
    • 0025614370 scopus 로고
    • Interaction of cisplatin and noise on the peripheral auditory system
    • Gratton MA, Salvi RJ, Kamen BA, Saunders SS. Interaction of cisplatin and noise on the peripheral auditory system. Hear Res 1990;50:211-23.
    • (1990) Hear Res , vol.50 , pp. 211-223
    • Gratton, M.A.1    Salvi, R.J.2    Kamen, B.A.3    Saunders, S.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.